Pages that link to "Q37683681"
Jump to navigation
Jump to search
The following pages link to Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer (Q37683681):
Displaying 50 items.
- Prostate cancer stem cells: the role of androgen and estrogen receptors (Q26778415) (← links)
- Cellular Plasticity in Prostate Cancer Bone Metastasis (Q28085013) (← links)
- Role of periostin and its antagonist PNDA-3 in gastric cancer metastasis (Q28088349) (← links)
- Epithelial-mesenchymal transition in prostate cancer: an overview. (Q33798864) (← links)
- PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway (Q33827484) (← links)
- TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer. (Q34619422) (← links)
- The androgen receptor plays a suppressive role in epithelial- mesenchymal transition of human prostate cancer stem progenitor cells (Q35604311) (← links)
- Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes (Q36067956) (← links)
- By inhibiting snail signaling and miR-23a-3p, osthole suppresses the EMT-mediated metastatic ability in prostate cancer (Q36356259) (← links)
- Molecular analysis of CD133-positive circulating tumor cells from patients with metastatic castration-resistant prostate cancer (Q36440631) (← links)
- Androgen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition (Q36707740) (← links)
- Modulation of macrophage polarization and lung cancer cell stemness by MUC1 and development of a related small-molecule inhibitor pterostilbene (Q37457526) (← links)
- MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity (Q37565167) (← links)
- Loss of endothelial cell-specific molecule 1 promotes the tumorigenicity and metastasis of prostate cancer cells through regulation of the TIMP-1/MMP-9 expression (Q37706719) (← links)
- New advances in genitourinary cancer: evidence gathered in 2014. (Q38557894) (← links)
- Androgen-glucocorticoid interactions in the era of novel prostate cancer therapy (Q38661520) (← links)
- DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells. (Q38743845) (← links)
- Androgens induce a distinct response of epithelial-mesenchymal transition factors in human prostate cancer cells (Q38750022) (← links)
- Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma (Q38771232) (← links)
- PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells (Q38787568) (← links)
- PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells (Q38825075) (← links)
- Canine heat shock protein 27 promotes proliferation, migration, and doxorubicin resistance in the canine cell line DTK-F. (Q38886060) (← links)
- Non-coding RNAs Functioning in Colorectal Cancer Stem Cells (Q38940597) (← links)
- CK2 abrogates the inhibitory effects of PRH/HHEX on prostate cancer cell migration and invasion and acts through PRH to control cell proliferation. (Q38992187) (← links)
- Investigational serine/threonine kinase inhibitors against prostate cancer metastases (Q39021945) (← links)
- Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer (Q39152842) (← links)
- Ecotropic viral integration site 1, a novel oncogene in prostate cancer (Q39401617) (← links)
- Association of microRNA-21 expression with clinicopathological characteristics and the risk of progression in advanced prostate cancer patients receiving androgen deprivation therapy (Q39867322) (← links)
- miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110. (Q39966525) (← links)
- miR-618 Inhibits Prostate Cancer Migration and Invasion by Targeting FOXP2. (Q41243073) (← links)
- Expression of P-EGFR and P-Akt protein in esophageal squamous cell carcinoma and its prognosis (Q41613206) (← links)
- microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer (Q41824632) (← links)
- Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties (Q42078200) (← links)
- Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells (Q42315527) (← links)
- Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells. (Q42514114) (← links)
- Upregulation of microRNA-4417 and Its Target Genes Contribute to Nickel Chloride-promoted Lung Epithelial Cell Fibrogenesis and Tumorigenesis (Q47108395) (← links)
- Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer. (Q47291146) (← links)
- Linking Race, Cancer Outcomes, and Tissue Repair. (Q47839645) (← links)
- Interleukin-6/signal transducer and activator of transcription 3 promotes prostate cancer resistance to androgen deprivation therapy via regulating pituitary tumor transforming gene 1 expression. (Q49483643) (← links)
- Selection-free method reveals phenotypic diversity among prostate cancer circulating tumour cells (Q50142579) (← links)
- Aberrant TGF-β Signaling Drives Castration-Resistant Prostate Cancer in a Male Mouse Model of Prostate Tumorigenesis (Q51092129) (← links)
- Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer (Q51311867) (← links)
- Shp2 promotes metastasis of prostate cancer by attenuating the PAR3/PAR6/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition. (Q52660753) (← links)
- Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4. (Q53410584) (← links)
- p53-dependent CD51 expression contributes to characteristics of cancer stem cells in prostate cancer. (Q53685182) (← links)
- Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF-κB signaling (Q57116175) (← links)
- Cotargeting the Cell-Intrinsic and Microenvironment Pathways of Prostate Cancer by PI3Kα/β/δ Inhibitor BAY1082439 (Q57449225) (← links)
- Prostate Luminal Progenitor Cells in Development and Cancer (Q57789213) (← links)
- High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells (Q64074308) (← links)
- The human positive cofactor 4 promotes androgen-independent prostate cancer development and progression through HIF-1α/β-catenin pathway (Q64087620) (← links)